Display options
Share it on

IEEE J Transl Eng Health Med. 2016 Sep 08;4:2800708. doi: 10.1109/JTEHM.2016.2604485. eCollection 2016.

The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income Countries.

IEEE journal of translational engineering in health and medicine

Paul C Pearlman, Rao Divi, Michael Gwede, Pushpa Tandon, Brian S Sorg, Miguel R Ossandon, Lokesh Agrawal, Vinay Pai, Houston Baker, Tiffani Bailey Lash

Affiliations

  1. National Cancer Institute, National Institutes of Health Department of Health and Human Services Bethesda MD 20892 USA.
  2. National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health Department of Health and Human Services Bethesda MD 20892 USA.

PMID: 27730015 PMCID: PMC5052025 DOI: 10.1109/JTEHM.2016.2604485

Abstract

Point-of-care (POC) technologies have proved valuable in cancer detection, diagnosis, monitoring, and treatment in the developed world, and have shown promise in low-and-middle-income countries (LMIC) as well. Despite this promise, the unique design constraints presented in low-resource settings, coupled with the variety of country-specific regulatory and institutional dynamics, have made it difficult for investigators to translate successful POC cancer interventions to the LMIC markets. In response to this need, the National Cancer Institute has partnered with the National Institute of Biomedical Imaging and Bioengineering to create the National Institutes of Health Affordable Cancer Technologies (ACTs) program. This program seeks to simplify the pathway to market by funding multidisciplinary investigative teams to adapt and validate the existing technologies for cancer detection, diagnosis, and treatment in LMIC settings. The various projects under ACTs range from microfluidic cancer diagnostic tools to novel treatment devices, each geared for successful clinical adaptation to LMIC settings. Via progression through this program, each POC innovation will be uniquely leveraged for successful clinical translation to LMICs in a way not before seen in this arena.

Keywords: Cancer; cancer detection; computer aided diagnosis; cryotherapy; medical diagnosis

References

  1. Obstet Gynecol. 1999 Aug;94(2):307-10 - PubMed
  2. BMC Health Serv Res. 2013 Aug 10;13:304 - PubMed
  3. Lancet. 2010 Jun 12;375(9731):2051 - PubMed
  4. Gynecol Oncol. 2014 May;133(2):353-61 - PubMed
  5. J Clin Microbiol. 2006 Apr;44(4):1310-7 - PubMed
  6. Int J Gynaecol Obstet. 2005 May;89 Suppl 2:S13-20 - PubMed

Publication Types